Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fergus J Couch

Showing results (31-40 of 563) with videos related to

Pageof 57
Sort By:
Mayo Clinic Proceedings|June 8, 2019
Hereditary Cancer Syndromes-A Primer on Diagnosis and Management, Part 2: Gastrointestinal Cancer SyndromesN Jewel Samadder, Noemi Baffy, Karthik V Giridhar, et al.
Developmental Cell|July 10, 2012
BRCA2 localization to the midbody by filamin A regulates cep55 signaling and completion of cytokinesisGourish Mondal, Matthew Rowley, Lucia Guidugli, et al.
Human Mutation|October 28, 2008
Prediction and assessment of splicing alterations: implications for clinical testingAmanda B Spurdle, Fergus J Couch, Frans B L Hogervorst, et al.
The Oncologist|April 26, 2013
BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical managementNoralane M Lindor, David E Goldgar, Sean V Tavtigian, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 9, 2015
A preliminary investigation of genetic counselors' information needs when receiving a variant of uncertain significance result: a mixed methods studyCourtney L Scherr, Noralane M Lindor, Teri L Malo, et al.
Breast Cancer Research : BCR|November 11, 2016
The PALB2 p.Leu939Trp mutation is not associated with breast cancer riskIrene Catucci, Paolo Radice, Roger L Milne, et al.
Annals of Surgical Oncology|July 22, 2017
Management of Breast Cancer Risk in Women with Ovarian Cancer and Deleterious BRCA1 or BRCA2 MutationsAndrea E Wahner Hendrickson, Jamie N Bakkum-Gamez, Fergus J Couch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2008
Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significanceAndrew D Spearman, Kevin Sweet, Xiao-Ping Zhou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 31, 2011
A computational method to classify variants of uncertain significance using functional assay data with application to BRCA1Edwin S Iversen, Fergus J Couch, David E Goldgar, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2010
Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcomeFergus J Couch, Xianshu Wang, William R Bamlet, et al.
Pageof 57

Showing results (31-40 of 563) with videos related to

Sort By:
Pageof 57
Mayo Clinic Proceedings|June 8, 2019
Hereditary Cancer Syndromes-A Primer on Diagnosis and Management, Part 2: Gastrointestinal Cancer SyndromesN Jewel Samadder, Noemi Baffy, Karthik V Giridhar, et al.
Developmental Cell|July 10, 2012
BRCA2 localization to the midbody by filamin A regulates cep55 signaling and completion of cytokinesisGourish Mondal, Matthew Rowley, Lucia Guidugli, et al.
Human Mutation|October 28, 2008
Prediction and assessment of splicing alterations: implications for clinical testingAmanda B Spurdle, Fergus J Couch, Frans B L Hogervorst, et al.
The Oncologist|April 26, 2013
BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical managementNoralane M Lindor, David E Goldgar, Sean V Tavtigian, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 9, 2015
A preliminary investigation of genetic counselors' information needs when receiving a variant of uncertain significance result: a mixed methods studyCourtney L Scherr, Noralane M Lindor, Teri L Malo, et al.
Breast Cancer Research : BCR|November 11, 2016
The PALB2 p.Leu939Trp mutation is not associated with breast cancer riskIrene Catucci, Paolo Radice, Roger L Milne, et al.
Annals of Surgical Oncology|July 22, 2017
Management of Breast Cancer Risk in Women with Ovarian Cancer and Deleterious BRCA1 or BRCA2 MutationsAndrea E Wahner Hendrickson, Jamie N Bakkum-Gamez, Fergus J Couch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2008
Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significanceAndrew D Spearman, Kevin Sweet, Xiao-Ping Zhou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 31, 2011
A computational method to classify variants of uncertain significance using functional assay data with application to BRCA1Edwin S Iversen, Fergus J Couch, David E Goldgar, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2010
Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcomeFergus J Couch, Xianshu Wang, William R Bamlet, et al.
Pageof 57